Lisa • January 4, 2023
Responding to Sudden Cardiac Arrest: The Damar Hamlin teachable moment

Commotio Cordis appears to have occurred at the Bill’s game, Monday, January 2, 2023, with the collapse of Damar Hamlin. If you don’t know what this is… sudden cardiac arrest occurs after a chest blow. While uncommon, it speaks to the need for AEDs on all playing fields. The HCMA shares in the hopes for a positive outcome for this young man.

Sudden Cardiac arrest occurs out of the hospital nearly 1000 times a day from many different root causes.

Are you prepared to respond at home, at work, at the gym, or during a game? AEDs and well-done CPR can be all the difference between life and death. Create an action plan today. Download the Dr. Drill kit here.

Pictured here is Dr. Mark Link, a pioneering researcher on commotio cordis and dear friend.

I’m proud of all the researchers, clinical experts, advocates, patient safety experts, and all my heart warriors who have helped advance the science and change public policy to prepare to respond to sudden cardiac arrest. We never know when it will occur; however, prompt use after CPR and an Automatic External Defibrillator AED can significantly improve survival.

These situations can bring back very traumatic memories for families who have had personal experiences with sudden cardiac arrest. Let’s hope that all the preparation, planning, practice, and persistence will pay off for this young man… and the others who will not capture the public’s attention.

Learn more about putting together a plan for your team using the Dr. Heart Drill to prepare
for cardiac arrest response

Here are the basics of the “Dr. Heart” drill. Know the chain of survival and YOUR part in it:
● Early Access to the patient, including early recognition of the condition and call for
help. Chance of survival increases by 5%
● Early Basic Life Support (Rescue Breathing and External Chest Compressions), Chance
of survival increases by 10%
● Early Defibrillation (An electric shock to restart the heart) Chance of survival increases
by 75%
● Early Advanced Life Support (Drug therapies to maintain condition)

Do you know the difference between a Sudden Cardiac Arrest and a Heart Attack?

HCMA Blog

Pro Publica Releases Results of FDA Investigation

By Erica Friedman • June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
A light blue and dark blue paintbrush stroke intersect to make a stylized

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)

By Erica Friedman • June 18, 2025
Alnylam press release on the European Commission approval of AMVUTTRA® (vutrisiran) forwild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM) as an additional indication
Light & dark blue brush stroke that intersect create an abstract letter 'a' next to the word Alnylam

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran) for Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)

By Erica Friedman • June 17, 2025
AMVUTTRA® (vutrisiran) has been approved by the U.S. Food and Drug Administration (FDA) to treat ATTR-CM in adults.
More Posts